Description
Tesamorelin is an FDA-approved prescription injectable medication (brand name Egrifta SV) primarily used to reduce excess visceral abdominal fat in HIV-positive adults with lipodystrophy. As a synthetic growth hormone-releasing factor (GRF) analog, it stimulates the pituitary gland to produce more growth hormone, which helps decrease fat, improve metabolic markers, and potentially boost lean muscle mass

Reviews
There are no reviews yet.